Skip to main content
Have a personal or library account? Click to login
Pharmacological influence on processes of adjuvant arthritis: effect of the combination of an antioxidant active substance with methotrexate Cover

Pharmacological influence on processes of adjuvant arthritis: effect of the combination of an antioxidant active substance with methotrexate

Open Access
|Nov 2012

References

  1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS(1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.: 315-24.
  2. Babior BM. (2000). Phagocytes and oxidative stres.: 33-44.
  3. Baskol G, Demir H, Baskol M, Kilic E, Ates F, Kocer D. Muhtaroglu S. (2005). Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem: 951- 955.
  4. Baskol G, Demir H, Baskol M, Kilic E, Ates F, Karakukcu C, Ustdal M. (2006). Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Func307-311.
  5. Bauerova K, Bezek S. (1999). Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis.: 15-20.
  6. Bauerova K, Kucharska J, Mihalova D, Navarova J, Gvozdjakova A, Sumbalova Z. (2005a). Eff ect of coenzyme Q(10) supplementation in the rat model of adjuvant arthritis.: 501-503.
  7. Bauerova K, Valentova J, Ponist S, Navarova J, Komendova D, Mihalova, D. (2005b). Eff ect of copper complexes on the development of adjuvant arthritis: Therapeutic and toxicological aspects.: 65-68.
  8. Bauerova K, Ponist S, Ondrejickova O, Komendova D. Mihalova D. (2006). Association between tissue gamma-glutamyl-transferase and clinical markers of adjuvant arthritis in Lewis rats. Neuroendocrinol Lett: 172-175.
  9. Bauerova K, Kucharska J, Ponist S, Gvozdjakova A. (2008a). Coenzyme Q10 supplementation in adjuvant arthritis (pre-clinical study), in:(Gvozdjakova A. eds) pp. 340-342, Springer, Netherlands.
  10. Bauerova K, Ponist S, Navarova J, Dubnickova M, Paulovicova E, Pajtinka M, Kogan G, Mihalova D, (2008b). Glucomannan in prevention of oxidative stress and infammation occuring in adjuvant arthritis.: 691-696.
  11. Bauerova K, Paulovicova E, Mihalova D, Svik K, Ponist S. (2009). Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukan in adjuvant arthritis. Toxicology and Industrial Health329-335.
  12. Bauerova K, Paulovičova E, Mihalova D, Drafi F, Ktrosova M, Mascia C, Biasi F, Rovensky J, Kucharska J, Gvozdjakova A, Ponint S. (2010). Combined methotrexate and coenzyme Q10 therapy in adjuvant-induced arthritis evaluated using parameters of infl ammation and oxidative stress.347-354.
  13. Bauerova K, Ponist S, Nosal R, Stancikova M, Rovensky J. (2011). Modern pharmacological approaches to therapies: substances tested in animal models of rheumatoid arthritis, in Rheumatoid arthritis - Treatment 1 th: (Lemmey AD eds) pp 233-268, Intech, Rijeka. ISBN 978-953-307-850-2.
  14. Bauerova K, Ponist S, Kuncirova V, Mihalova D, Paulovicova E, Volpi N. (2011). Chondroitin sulfate eff ect on induced arthritis in rats. Osteoarthritis Cartilage.: 1373-1379.
  15. Bina J, Wilder RL (1999). Animal models of rheumatoid arthritis.367-369.
  16. Boldyrev, AA, Severin, SE. (1990). The histidine-containing dipeptides, carnosine, and anserine: distribution, properties, and biological significance.: 175-193.
  17. Boldyrev, AA. (1990). Retrospectives and perspectives on the biological activity of histidine- containing dipeptides.: 129-132.
  18. Connolly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T (1988) Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate.717-728.
  19. Dobrota D, Fedorova T, Stvolinsky S, Babushikova E, Licavcanova K, Drgova A, Strapkova A, Boldrev A. (2005). Carnosine protects the brain of rats and mongolian gerbils against ischemic injury: after-stroke-effect.: 1283-1288.
  20. Drabikova K, Perecko T, Nosal R, Bauerova K, Ponist S, Mihalova D, Kogan G, Jancinova, V. (2009). Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis.: 399-403.
  21. Drafi F, Bauerova K, Valachova K, Poništ S, Mihalova D, Juranek I, Boldyrev A, Hrabarova E, Soltes L. (2010). Carnosine inhibits degradation of hyaluronan induced by free radical processes in vitro and improves the redox imbalance in adjuvant arthritis in vivo.: 96-100.
  22. Fedorova TN, Boldyrev AA, Gannushkina IV. (1999) Lipid peroxidation in experimental ischemia of the brain.)75-79.
  23. Feketeova L, Jančova P, Moravcova P, Janegova A, Bauerova K, Poništ S, Mihalova D, Janega P, Babal P. (2011) Eff ect of methotrexate on infl ammatory cells redistribution in experimental adjuvant arthritis.(DOI 10.1007/s00296-011-2177-3).
  24. Harmatha J, Zidek Z, Kmoničkova E, Šmidrkal J. (2011). Immunobiological properties of selected natural and chemically modifi ed phenylpropanoids.: 5-10.
  25. He YH, Zhou J, Wang YS, Xiao C, Tong Y, Tang JC, Chan AS, Lu AP. (2006). Antiinfammatory and anti-oxidative eff ects of cherries on Freund’s adjuvantinduced arthritis in rats. Scand J Rheumatol: 356-358.
  26. Herman S, Zurgil N, Langevitz P, Ehrenfeld M, Deutsch M. (2008). Methotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis patients.317-323.
  27. Ishizuka Y, Moriwaki S, Kawahara-Hanaoka M, Uemura Y, Serizawa I, Miyauchi M, Shibata S, Kanaya T, Takata T, Taniguchi N, Niida S. (2007) Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.: 1933-42.
  28. Jancinova V, Perecko T, Nosal R, Kostalova D, Bauerova K, Drabikova K. (2009). Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition.: 161-6.
  29. Jaswal S, Mehta HC, Sood AK, Kaur J. (2003). Antioxidant status in rheumatoid arthritis and role of antioxidant therapy.: 123-129.
  30. Jurcovicova J, Svik K, Scsukova S, Bauerova K, Rovensky J, Stancikova M. (2009). Methotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritis.1187-1191.
  31. Kageyama Y, Takahashi M, Nagafusa T, Torikai E, Nagano A. (2007). Methotrexate reduces the levels of pentosidine and 8- hydroxy-deoxy guanosine in patients with rheumatoid arthritis.398-402.
  32. Kogan G, Staško A, Bauerova K, Polovka M, Šoltes L, Brezova V, Navarova J, Mihalova D. (2005). Antioxidant properties of yeast (1/3)-β-D-glucan studied by electron paramagnetic resonance spectroscopy and its activity in adjuvant arthritis.: 18-28.
  33. Koner BC, Banrejee BD, Ray A. (1997). Efects of stress on gamma- glutamyl transpeptidase activity in lymphoid system of rats: modulation by drugs.: 222-224.
  34. Kunsch CH, Sikorski JA, Sundell CL. (2005). Oxidative stress and the use of antioxidants for the treatment of rheumatoid arthritis.: 249-258.
  35. Macickova T, Drabikova K, Nosal R, Bauerova K, Mihalova D, Harmatha J, Pecivova J. (2010). In vivo eff ect of pinosylvin and pterostilbene in the animal model of adjuvant arthritis.: 91-95.
  36. Mihalova D, Ponist S, Kucharska J, Komendova D, Bauerova K. (2007). Total antioxidant status-systemic marker of oxidative stress in adjuvant arthritis.225-226.
  37. Nosal R, Jančinova V, Petrikova M, Ponint S, Bauerova K. (2007). Suppression of oxidative burst of neutrophils with methotrexate in rat adjuvant arthritis.243-244.
  38. Ponist S, Mihalova D, Jancinova V, Snirc V, Ondrejickova O, Mascia C, Poli G, Stancikova M, Nosal R, Bauerova K. (2010). Reduction of oxidative stress in adjuvant arthritis. Comparison of effi cacy of two pyridoindoles: stobadine dipalmitate and SMe1.2HCl.: 223-228.
  39. Rambabu K, Ansari AA, Shaafe IA, Chelvam AP, Ziu MM.(1990). Gamma-glutamyl transpeptidas in synovial fl uid, serum, and urine of patients with rheumatoid arthritis. Biochem Med Metab Biol: 183-192.
  40. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. (1958). Revision of diagnostic criteria for rheumatoid arthritis.: 16-203
  41. Roupe KA, Remsberg CM, Yańez JA, Davies NM (2006). Pharmacometric of Stilbenes: Seguing Towards the Clinic.: 81-101.
  42. Sarban A, Kocyigit A, Yazar M, Isikan UE. (2005). Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem981-986.
  43. Šmidrkal J, Harmatha J, Buděšinsky M, Vokač K, Zidek Z, Kmoničkova E, Merkl R, Filip V. (2010). Modifi ed approach for preparing (E)-stilbens related to resveratrol, and evaluation of their potential immunobiological eff ects.: 175-186.
  44. Sotnikova R, Ponist S, Navarova J, Mihalova D, Tomekova V, Strosova M, Bauerova K. (2009). Eff ects of sesame oil in the model of adjuvant arthritis.: 22-24.
  45. Storey GO, Comer M, Scott DL. (1994). Chronic arthritis before 1876: early British cases suggesting rheumatoid arthritis.: 557-60.
  46. Strosova M, Tomaskova I, Ponist S, Bauerova K, Karlovska J, Spickett CM, Horakova L. (2008). Oxidative impairment of plasma and skeletal muscle sarcoplasmic reticulum in rats with adjuvant arthritis - eff ects of pyridoindole antioxidants.: 706-711.
  47. Strosova M, Karlovska J, Spickett CM, Orszaghova Z, Ponist S, Bauerova K, Mihalova D, Horakova L, (2009). Modulation of SERCA in the chronic phase of adjuvant arthritis as a possible adaptation mechanism of redox imbalance.: 852-864.
  48. Tastekin N, Aydogdu N, Dokmeci D, Usta U, Birtane M, Erbas H, Ture M. (2007). Protective eff ects of L-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol Res303-310.
  49. Thompson D, Pepys MB, Wood SP. (1999). The physiological structure of human C-reactive protein and its complex with phosphocholine.: 169-77.
  50. Welles WL, Silkworth J, Oronsky AL, Kerwar SS, Galivan J. (1985) Studies on the eff ect of low dose methotrexate in adjuvant arthritis.904-906.
DOI: https://doi.org/10.2478/v10102-012-0015-4 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 84 - 91
Published on: Nov 9, 2012
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2012 Frantisek Drafi, Katarina Bauerova, Viera Kuncirova, Silvester Ponist, Danica Mihalova, Tatiana Fedorova, Juraj Harmatha, Radomir Nosal, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.